Collegium Pharmaceutical Non-GAAP EPS of $2.25 beats by $0.39, revenue of $209.4M beats by $20.28M (NASDAQ:COLL)
Collegium PharmaceuticalCollegium Pharmaceutical(US:COLL) Seeking Alpha·2025-11-06 12:34

Group 1 - The article does not provide any specific content or key points related to a company or industry [1]